A large genome-wide analysis reports that common obesity traits share, and in some cases drive, risk for diabetic kidney ...

Launched on 06/23/2005, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ...

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the Invesco Biotechnology & Genome ETF (PBE) is a passively managed exchange traded fund launched on June ...

In 2013, a Redding cleanup crew discovered a human skull in a patch of blackberry bushes along an irrigation canal. Despite a ...

Reading determines almost all aspects of everyday life. Reading allows you to learn in school, to read signs, to read books, ...

Research indicates that disease susceptibility genetics poorly predict survival, while longevity PGSs offer stronger ...

Robert Langer, a hugely influential biotech innovator, expects the industry will get through its latest slowdown. He's more ...

The Fund had a strong second quarter, outperforming its benchmarks, the Russell 1000 Growth Index and the S&P 500 Index. Read ...

Of the 30 companies in the index, 18 firms saw their share prices increase month over month, while 12 saw their stock prices decline.

Diversify Outside the U.S. Heavyweights: Global healthcare ETFs like iShares Global Healthcare ETF (NYSE: MIXJ) provide ...

Non-reversible nucleotide substitution models best describe strand-specific nucleotide substitution biases of viral genomes.

Background: Porcine genome editing has revolutionized xenotransplantation, recently enabling the first pig-to-human heart xenotransplants. However, the xeno-immune response in heart xenografts remains ...